Sharon Drobnak Maffei

Sharon Drobnak Maffei is an experienced healthcare sales professional with a strong background in oncology and rare diseases. Currently serving as a Key Account Manager for Geron Corporation, specializing in Myelodysplastic Syndromes since April 2024, Sharon previously held roles including Sr. Cell Therapy Account Specialist at Kite Pharma, where expertise focused on lymphoma and leukemia. With earlier positions encompassing key account management and oncology account management at companies such as EUSA Pharma US, Oncopeptides AB, and Dova Pharmaceuticals, Sharon has demonstrated a successful track record in launching and promoting critical therapies across various regions. A former Senior Oncology Sales Specialist at Novartis Oncology, Sharon excelled in launching Zykadia and was recognized for ranking among the top territories nationally. Sharon's career began at TAP Pharmaceuticals as a Senior Sales Representative, where responsibilities included sales, promotion, and education in urology and oncology settings. Sharon Drobnak Maffei holds a Bachelor of Applied Science degree from Marywood University.